Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years

Apellis Pharmaceuticals APLS has outperformed the market over the past 5 years by 23.37% on an annualized basis producing an average annual return of 36.05%. Currently, Apellis Pharmaceuticals has a market capitalization of $8.01 billion.

Buying $100 In APLS: If an investor had bought $100 of APLS stock 5 years ago, it would be worth $451.80 today based on a price of $67.59 for APLS at the time of writing.

Apellis Pharmaceuticals's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.